Early Access — free while we kick the tires
EdgarHawk

Samuel George A. III

General Counsel

Officer
1 filing analyzed · 1 company · Latest 2024-11-26

Companies

Company Buys Sells Direction
Lineage Cell Therapeutics, Inc. LCTX 1 0 Net buying

Activity

November 2024
Buy
15,000 shares
$9,000
Significance 7/10

General Counsel Samuel George A. III purchases 15,000 shares at $0.60 as part of cluster buy; stock down 59.5% from 52-week high amid -39.2% annual revenue decline.

Samuel George A. III, as General Counsel, purchased 15,000 shares at $0.60, increasing his holdings by 208.8% to 22,184 shares. This purchase is part of a cluster buy pattern with 3 other insiders also buying within the past 14 days. The transaction occurs against a backdrop of significant operational deterioration: annual revenue declined 39.2%, the company generated a net loss of $3,034,000.00 in its latest quarter, and the stock has fallen 59.5% from its 52-week high of $1.48. The substantial insider accumulation at these depressed levels, combined with concurrent buying by multiple executives, occurs as the company faces profitability challenges and sharply declining revenue, warranting scrutiny of whether insiders possess non-public information regarding a strategic inflection.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access